Stanford parameters stratify the risk of recurrence in gynecologic smooth muscle tumors of uncertain malignant potential
Antonio Travaglino(University of Insubria), Luigi Insabato(Federico II University Hospital), Fulvio Zullo(Magna Graecia University), Gian Franco Zannoni(Università Cattolica del Sacro Cuore), Annarita Gencarelli(University of Naples Federico II), Marcello Granata(University of Naples Federico II), Antonio Raffone(University of Campania "Luigi Vanvitelli"), Antonio Mollo(Northwestern University), Carola Caldarelli(University of Naples Federico II), Angela Santoro(Ospedale Santa Maria Goretti)
Cited by 13
Related Papers
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|281
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
|The Journal of Clinical Endocrinology & Metabolism|2004|276
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|254